Adults over the age of 60 are recommended not to get the chikungunya vaccine to prevent the mosquito-borne illness due to two ...

The FDA and CDC recommended a pause for Ixchiq, a chikungunya vaccine, following reports of adverse events in recipients 60 ...

TUESDAY, May 13, 2025 (HealthDay News) — U.S. health officials are telling travelers aged 60 and older to avoid a chikungunya ...

A half-decade since the pandemic, countless individuals and families have been left wondering: what is the long-term safety ...

A study of more than one million people found the shingles vaccine may lower the risk of heart disease and stroke for up to ...

The U.S. government is advising that international travelers age 60 and older not get a chikungunya vaccine as it ...

A new study suggests the shingles vaccine may reduce the risk of heart disease for up to eight years post-vaccination. A ...

The Trump administration has launched a $500 million project to develop a universal flu vaccine that won't need yearly ...

The CDC began recommending Ixchiq last year for adults traveling to countries where chikungunya is common. The vaccine uses a ...

In this study, those who had the Zostavax vaccine had a 3.5% point reduction in a new dementia diagnosis over seven years, ...

The Trump administration's FDA and CDC is advising U.S. patients using the drug Ixchiq to hold off while U.S. health ...

The shingles vaccine has benefits that stretch beyond protecting older adults from the painful skin condition, a new study ...